Elsius Biomedical is a Canadian startup based in Calgary that aims to produce and commercialize a worldwide ECMO system that addresses the shortcomings of current clinical systems. The company’s revolutionary system is based on a compact, integrated device design that leverages a proprietary biocompatible coating (EBS) specifically developed for ECLS (Extra Corporeal Life Support) applications. In this startup showcase, we take a closer look at how Elsius Biomedical is redefining ECMO systems.
Revolutionizing ECMO Systems
ECMO systems are used to support patients with severe respiratory or cardiac failure. However, current clinical systems have shortcomings that are not optimal for patient recovery and cost containment. This ultimately results in a higher number of lives lost, longer hospitalization times, and higher costs to healthcare systems worldwide. Elsius Biomedical aims to revolutionize the ECMO industry by producing and commercializing a worldwide ECMO system that addresses these shortcomings. The Elsius system leverages a proprietary biocompatible coating (EBS) that reduces the inflammatory response associated with the procedure, making it arguably superior to anything on the market today.
Proprietary Biocompatible Coating (EBS)
Elsiuss’ ECMO system leverages a proprietary biocompatible coating (EBS) that is specifically developed for ECLS applications. The EBS coating is revolutionary in the sense that it reduces the inflammatory response associated with the procedure, leading to faster patient recovery times and better outcomes. The proprietary biocompatible coating has been extensively tested and is expected to be a game-changer in the ECMO industry.
Expert Management Team
Elsius Biomedical has a combined expertise in medical devices start-up companies of more than 60 years. The management team is led by Mr. Alessandro Biglioli, a serial entrepreneur with a history of successes (this is his 14th company). He has direct experience in blood oxygenation devices and how to develop, certify, produce, and sell them. With his expertise and the team’s combined experience, Elsius Biomedical is well-positioned to revolutionize the ECMO industry.
Conclusion
Elsius Biomedical is a Canadian startup that aims to produce and commercialize a worldwide ECMO system that addresses the shortcomings of current clinical systems. The company’s revolutionary system is based on a compact, integrated device design that leverages a proprietary biocompatible coating (EBS) specifically developed for ECLS applications. With an expert management team and a revolutionary product, Elsius Biomedical is well-positioned to revolutionize the ECMO industry and improve patient outcomes worldwide.
Website: https://elsius.com
Twitter: https://twitter.com/elsiusbiomed?lang=en
LinkedIn: https://www.linkedin.com/company/elsiusbiomedical/?originalSubdomain=ca
Looking to amplify your brand’s impact in Canada’s thriving startup and investment sector? Join the league of innovators, leaders, and decision-makers making a difference through Canada Venture News. Engage with our audience of startup founders, investors, and executives through sponsored articles and partnerships. Discover more on our Promotion & Sponsored Articles page or email us directly at [email protected]. Let’s shape your story together.
